Literature DB >> 22901532

CRISPR-Cas: to take up DNA or not-that is the question.

Ariel D Weinberger1, Michael S Gilmore.   

Abstract

Landmark experiments in the 1920s showed that capsule switching is critical for Streptococcus pneumonia survival. Further studies demonstrated that capsule "transformation" occurs via DNA uptake. In this issue of Cell Host and Microbe, Bikard et al. (2012) show that CRISPR-Cas systems inhibit DNA uptake, selecting for the outgrowth of CRISPR-defective pneumococci.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID： 22901532      PMCID： PMC3427645          DOI： 10.1016/j.chom.2012.07.007

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  9 in total

Review 1.  RNA-guided genetic silencing systems in bacteria and archaea.

Authors:  Blake Wiedenheft; Samuel H Sternberg; Jennifer A Doudna
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

2.  The Significance of Pneumococcal Types.

Authors:  F Griffith
Journal:  J Hyg (Lond)       Date:  1928-01

3.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

4.  CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.

Authors:  David Bikard; Asma Hatoum-Aslan; Daniel Mucida; Luciano A Marraffini
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

5.  H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO.

Authors:  Edze R Westra; Umit Pul; Nadja Heidrich; Matthijs M Jore; Magnus Lundgren; Thomas Stratmann; Reinhild Wurm; Amanda Raine; Melina Mescher; Luc Van Heereveld; Marieke Mastop; E Gerhart H Wagner; Karin Schnetz; John Van Der Oost; Rolf Wagner; Stan J J Brouns
Journal:  Mol Microbiol       Date:  2010-08-18       Impact factor: 3.501

6.  Multidrug-resistant enterococci lack CRISPR-cas.

Authors:  Kelli L Palmer; Michael S Gilmore
Journal:  mBio       Date:  2010-10-12       Impact factor: 7.867

7.  Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria.

Authors:  Bruce R Levin
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

8.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

9.  Comparative genomics of enterococci: variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus.

Authors:  Kelli L Palmer; Paul Godfrey; Allison Griggs; Veronica N Kos; Jeremy Zucker; Christopher Desjardins; Gustavo Cerqueira; Dirk Gevers; Suzanne Walker; Jennifer Wortman; Michael Feldgarden; Brian Haas; Bruce Birren; Michael S Gilmore
Journal:  MBio       Date:  2012-03-01       Impact factor: 7.867
  9 in total
  9 in total

1.  Evolutionary dynamics of the prokaryotic adaptive immunity system CRISPR-Cas in an explicit ecological context.

Authors:  Jaime Iranzo; Alexander E Lobkovsky; Yuri I Wolf; Eugene V Koonin
Journal:  J Bacteriol       Date:  2013-06-21       Impact factor: 3.490

Review 2.  CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.

Authors:  Eugene V Koonin; Kira S Makarova
Journal:  RNA Biol       Date:  2013-02-25       Impact factor: 4.652

Review 3.  Evolution of the CRISPR-Cas adaptive immunity systems in prokaryotes: models and observations on virus-host coevolution.

Authors:  Eugene V Koonin; Yuri I Wolf
Journal:  Mol Biosyst       Date:  2014-09-19

Review 4.  Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era.

Authors:  Michael S Gilmore; Francois Lebreton; Willem van Schaik
Journal:  Curr Opin Microbiol       Date:  2013-02-05       Impact factor: 7.934

5.  Immunity, suicide or both? Ecological determinants for the combined evolution of anti-pathogen defense systems.

Authors:  Jaime Iranzo; Alexander E Lobkovsky; Yuri I Wolf; Eugene V Koonin
Journal:  BMC Evol Biol       Date:  2015-03-13       Impact factor: 3.260

6.  Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.

Authors:  Martha Lorena Ostria-Hernández; Carlos Javier Sánchez-Vallejo; J Antonio Ibarra; Graciela Castro-Escarpulli
Journal:  BMC Res Notes       Date:  2015-08-04

7.  Differential Distribution of Type II CRISPR-Cas Systems in Agricultural and Nonagricultural Campylobacter coli and Campylobacter jejuni Isolates Correlates with Lack of Shared Environments.

Authors:  Bruce M Pearson; Rogier Louwen; Peter van Baarlen; Arnoud H M van Vliet
Journal:  Genome Biol Evol       Date:  2015-09-02       Impact factor: 3.416

Review 8.  Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy.

Authors:  Roghiyeh Pashaei-Asl; Khodadad Khodadadi; Fatima Pashaei-Asl; Gholamreza Haqshenas; Nasser Ahmadian; Maryam Pashaiasl; Reza Hajihosseini Baghdadabadi
Journal:  Adv Pharm Bull       Date:  2017-06-30

9.  A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications.

Authors:  Martina Aulitto; Laura Martinez-Alvarez; Gabriella Fiorentino; Danila Limauro; Xu Peng; Patrizia Contursi
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.